Citi Pharma Limited (PSX:CPHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
61.79
-1.28 (-2.03%)
At close: Nov 6, 2026

Citi Pharma Financials Overview

Millions PKR. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
14,22014,07613,15412,40912,3979,780
Revenue Growth
6.92%7.01%6.00%0.10%26.76%68.75%
Gross Profit
2,6282,4732,0181,5861,5071,363
Operating Income
2,0311,9401,6041,2061,167993.48
Net Income
835.44790.33892.04833.46657.98653.69
Earnings Per Share
3.663.463.903.652.882.88
EPS Growth
-6.52%-11.40%7.03%26.67%0%53.04%

Revenue by Geography

Fiscal Year
TTMFY 2026FY 2025
Period EndingJun '26 Jun '26 Jun '25
Pakistan
13,73913,73912,996
Unallocated
-138.75-138.75-211.45
Export
475.66475.66368.91
Total
14,07614,07613,154

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
274.08348.241,5901,4181,5802,000
Total Debt
3,0683,1002,9501,4551,843943.48
Net Cash (Debt)
-2,793-2,751-1,360-36.55-262.21,056
Net Cash Growth
------61.65%
Net Cash Per Share
-12.24-12.04-5.95-0.16-1.154.66

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
777.23162.06-320.71,338-329-322.97
Capital Expenditures
-804.66-706.69-150.06-568.2-954.47-600.46
Free Cash Flow
-27.43-544.63-470.77769.4-1,283-923.43
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
18.48%17.57%15.34%12.78%12.16%13.94%
Operating Margin
14.28%13.79%12.20%9.72%9.42%10.16%
Pretax Margin
10.09%9.55%10.30%10.32%7.72%10.84%
Profit Margin
5.88%5.62%6.78%6.72%5.31%6.68%
FCF Margin
-0.19%-3.87%-3.58%6.20%-10.35%-9.44%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23
Dividend Per Share
3.500-3.5003.2502.500
Dividend Per Share Growth
7.69%-7.69%30.00%-
Dividend Yield
5.66%-4.17%11.40%11.71%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
16.8922.5121.517.817.4111.41
Forward PE
-18.6814.236.556.34-
P/FCF Ratio
---8.46--
PS Ratio
1.011.261.460.530.390.76